CBRE Group Inc. CBRE is a commercial real estate services and investment company in the U.S., the U.K., and internationally.
If You Bought CBRE Stock 10 Years Ago
The company's stock traded at approximately $36.85 per share 10 years ago. If you had invested $10,000, you could have bought roughly 271 shares. Currently, shares trade at $127.64, meaning your investment's value could have grown to $34,638 from stock price appreciation.
That's a total return of 246.38%, outpacing the S&P 500's return of 241.36% over the same period.
Don't Miss:
- Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — you can become an investor for $0.80 per share today.
- If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it?
What Could The Next 10 Years Bring?
CBRE has a consensus rating of "Buy" and a price target of $143.30 based on the ratings of 10 analysts. The price target implies a more than 12% potential upside from the current stock price.
On April 24, the company announced its Q1 2025 earnings, posting adjusted EPS of $0.86, above the consensus estimate of $0.77, while revenues of $8.91 billion matched Street expectations, as reported by Benzinga.
Trending: Maximize saving for your retirement and cut down on taxes: Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation.
"CBRE had a strong start to 2025 across our lines of business and around the world. Notably, as the first quarter ended, most of our businesses were performing better than expected and our new business pipelines were strong. This was equally true for both our Resilient and Transactional businesses," said CEO Bob Sulentic.
Check out this article by Benzinga for seven analysts' insights on CBRE.
Given the historical stock price appreciation and expected upside potential, growth-focused investors may find CBRE stock attractive.
Read Next:
- Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.
- Arrived Home's Private Credit Fund’s has historically paid an annualized dividend yield of 8.1%*, which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum.
Image: Shutterstock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.